Nasacort (Triamcinolone Acetonide)

Triamcinolone acetonide, the active ingredient in Nasacort, is a corticosteroid presented as a nasal spray for intranasal use. The formulation delivers a measured dose of the glucocorticoid directly to the nasal mucosa, helping to control inflammation and improve breathing. It is indicated for the relief of symptoms associated with allergic rhinitis, including seasonal and perennial forms, in adults and children.

GNH USA supplies Nasacort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across EU and global markets.

Nasacort, a nasal corticosteroid, is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. Seasonal allergic rhinitis: provides symptom relief during pollen seasons. Perennial allergic rhinitis: controls year‑round nasal inflammation and associated symptoms.

Nasacort may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of nasal passages - Sneezing - Headache - Altered taste or smell - Epistaxis (nosebleed)

Serious or Rare Side Effects: - Nasal septal perforation - Severe or persistent nosebleeds - Vision changes or cataract formation - Adrenal suppression with prolonged use - Allergic reactions such as angioedema or anaphylaxis

When using Nasacort, follow safety guidelines to minimize risks.

Follow prescribed dosing schedule: use only as directed by a healthcare professional. Avoid use after nasal surgery or trauma: may impair healing. Caution in children: monitor growth with long‑term therapy. Do not combine with systemic corticosteroids without medical advice: increased systemic exposure. Monitor for signs of infection: nasal irritation may mask bacterial overgrowth. Store at room temperature: keep in the original container, protect from moisture and heat.

Nasacort can interact with other medicines; assess the level of risk before co‑administration.

Major Interactions (Avoid): - Systemic corticosteroids: risk of additive glucocorticoid effects and adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase local exposure. - Live vaccines: immunosuppression may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedative effects if combined with other sedating agents. - Decongestant nasal sprays (oxymetazoline): risk of increased nasal irritation. - Topical antifungal azoles: potential for increased local concentration.